NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|2462560624|ref|XP_054174678|]
View 

dymeclin isoform X7 [Homo sapiens]

Protein Classification

dymeclin( domain architecture ID 10560863)

dymeclin is necessary for correct organization of Golgi apparatus

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
Dymeclin pfam09742
Dyggve-Melchior-Clausen syndrome protein; Dymeclin (Dyggve-Melchior-Clausen syndrome protein) ...
1-618 0e+00

Dyggve-Melchior-Clausen syndrome protein; Dymeclin (Dyggve-Melchior-Clausen syndrome protein) contains a large number of leucine and isoleucine residues and a total of 17 repeated dileucine motifs. It is characteriztically about 700 residues long and present in plants and animals. Mutations in the gene coding for this protein in humans give rise to the disorder Dyggve-Melchior-Clausen syndrome (DMC, MIM 223800) which is an autosomal-recessive disorder characterized by the association of a spondylo-epi-metaphyseal dysplasia and mental retardation. DYM transcripts are widely expressed throughout human development and Dymeclin is not an integral membrane protein of the ER, but rather a peripheral membrane protein dynamically associated with the Golgi apparatus.


:

Pssm-ID: 462873  Cd Length: 645  Bit Score: 683.69  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624   1 MGSNSSRIGdlPKNEYLKKLSGTESISENDPFWNQLLSFSFPAPTSSSELKLLEEATISVCRSLVENNPRTGNLGALIKV 80
Cdd:pfam09742   1 MGASSSKLS--FRNAYLQLLSGTQPISADDPFWNQLLSFSLSIPLSSADVFLLEEALEPACEILALRNARTGNLATLLRK 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624  81 FLSRTKELK--LSAEC-QNHIFIWQTHNALFIICCLLKVFICQMSEEELQLHFTYEEKSPGNYSSDSEDLLEELLCCLM- 156
Cdd:pfam09742  79 FVERLVELKdsSRSASeQNDLFIWQALNALFLLRRILKYIIERASEEELLQHFEYENDDEGDEDEEGSNRDLPLAESLLl 158
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 157 ---QLITDIPLLDITYEISVEAISTMVVFLSCQLFHKEVLRQSISHKYLMRGPCL---PYTSKLVKTLLYNFIRQEKPPP 230
Cdd:pfam09742 159 alvDLLFTVPLTDSTYALHTELLNLLLVLLSEQLYSPPSPADTSIFNPFMDGKCSadsSIALPLVTSLLNNFIAYDPVPS 238
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 231 PGAHVFPQQSDGGGLLYGLASGVATGLWTVFTLGGvgSKAAASPELSSPLANQSLL-------LLLVLANLTDASDAPNP 303
Cdd:pfam09742 239 NSLDSDGGSGVPYNHLLGLVSDLASSLWLLPTLGG--SSESESEGTPEPLADQSLQlllvlldHGPTEDPVKSPSGGDNP 316
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 304 YRQAIMSFKNTQDsspfpssiphaFQINFNSLYTALCEQQTSDQA-TLLLYTLLHQNSNIRTYMLARTDMENLVLPILEI 382
Cdd:pfam09742 317 YRNALSRLHDVED-----------FQIVFSGLFRTLCNTVPSEQTlLLLLYKLLHSNSKFLNYVLSRSDVLDLLVPILEL 385
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 383 LYHVEERNSHHVYMALIILLILTEDDGFNRSIHEVILKNITWYSERVLTEISLGSLLILVVIRTIQYNMTRTRDKYLHTN 462
Cdd:pfam09742 386 LYNARADNSHHIYMALIILLILSEDRNFNKRLHKPILKNVTWYSERVPTEISLGSLLILVLIRTIQYNHTRLRDKYLHTN 465
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 463 CLAALANMSAQFRSLHQYAAQRIISLFSLLSKKHNKVLEQATQSLRGSLSSNdvplpDYAQDLNVIEEVIRMMLEIINSC 542
Cdd:pfam09742 466 CLAILANMSPYFKNLSPYASQRLVSLFELLSKKHFKLLSLANGKASNDLGSD-----DLAQDLSVNEEVLRLLLEILNSI 540
                         570       580       590       600       610       620       630
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 2462560624 543 LTNSLHHNPNLVYALLYKRDLFEQFRTHPSFQDIMQNIDLVISFFSSRLLQAGAE---LSVERVLEIIKQGVVALPKDR 618
Cdd:pfam09742 541 LQYQLDGNPNLVYALLRKREVFHQFANHPSFQDPLQNIDRVLQFFSPRVEKACADsglLSVSEILDIIQKGTLVGLLPK 619
 
Name Accession Description Interval E-value
Dymeclin pfam09742
Dyggve-Melchior-Clausen syndrome protein; Dymeclin (Dyggve-Melchior-Clausen syndrome protein) ...
1-618 0e+00

Dyggve-Melchior-Clausen syndrome protein; Dymeclin (Dyggve-Melchior-Clausen syndrome protein) contains a large number of leucine and isoleucine residues and a total of 17 repeated dileucine motifs. It is characteriztically about 700 residues long and present in plants and animals. Mutations in the gene coding for this protein in humans give rise to the disorder Dyggve-Melchior-Clausen syndrome (DMC, MIM 223800) which is an autosomal-recessive disorder characterized by the association of a spondylo-epi-metaphyseal dysplasia and mental retardation. DYM transcripts are widely expressed throughout human development and Dymeclin is not an integral membrane protein of the ER, but rather a peripheral membrane protein dynamically associated with the Golgi apparatus.


Pssm-ID: 462873  Cd Length: 645  Bit Score: 683.69  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624   1 MGSNSSRIGdlPKNEYLKKLSGTESISENDPFWNQLLSFSFPAPTSSSELKLLEEATISVCRSLVENNPRTGNLGALIKV 80
Cdd:pfam09742   1 MGASSSKLS--FRNAYLQLLSGTQPISADDPFWNQLLSFSLSIPLSSADVFLLEEALEPACEILALRNARTGNLATLLRK 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624  81 FLSRTKELK--LSAEC-QNHIFIWQTHNALFIICCLLKVFICQMSEEELQLHFTYEEKSPGNYSSDSEDLLEELLCCLM- 156
Cdd:pfam09742  79 FVERLVELKdsSRSASeQNDLFIWQALNALFLLRRILKYIIERASEEELLQHFEYENDDEGDEDEEGSNRDLPLAESLLl 158
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 157 ---QLITDIPLLDITYEISVEAISTMVVFLSCQLFHKEVLRQSISHKYLMRGPCL---PYTSKLVKTLLYNFIRQEKPPP 230
Cdd:pfam09742 159 alvDLLFTVPLTDSTYALHTELLNLLLVLLSEQLYSPPSPADTSIFNPFMDGKCSadsSIALPLVTSLLNNFIAYDPVPS 238
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 231 PGAHVFPQQSDGGGLLYGLASGVATGLWTVFTLGGvgSKAAASPELSSPLANQSLL-------LLLVLANLTDASDAPNP 303
Cdd:pfam09742 239 NSLDSDGGSGVPYNHLLGLVSDLASSLWLLPTLGG--SSESESEGTPEPLADQSLQlllvlldHGPTEDPVKSPSGGDNP 316
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 304 YRQAIMSFKNTQDsspfpssiphaFQINFNSLYTALCEQQTSDQA-TLLLYTLLHQNSNIRTYMLARTDMENLVLPILEI 382
Cdd:pfam09742 317 YRNALSRLHDVED-----------FQIVFSGLFRTLCNTVPSEQTlLLLLYKLLHSNSKFLNYVLSRSDVLDLLVPILEL 385
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 383 LYHVEERNSHHVYMALIILLILTEDDGFNRSIHEVILKNITWYSERVLTEISLGSLLILVVIRTIQYNMTRTRDKYLHTN 462
Cdd:pfam09742 386 LYNARADNSHHIYMALIILLILSEDRNFNKRLHKPILKNVTWYSERVPTEISLGSLLILVLIRTIQYNHTRLRDKYLHTN 465
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 463 CLAALANMSAQFRSLHQYAAQRIISLFSLLSKKHNKVLEQATQSLRGSLSSNdvplpDYAQDLNVIEEVIRMMLEIINSC 542
Cdd:pfam09742 466 CLAILANMSPYFKNLSPYASQRLVSLFELLSKKHFKLLSLANGKASNDLGSD-----DLAQDLSVNEEVLRLLLEILNSI 540
                         570       580       590       600       610       620       630
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 2462560624 543 LTNSLHHNPNLVYALLYKRDLFEQFRTHPSFQDIMQNIDLVISFFSSRLLQAGAE---LSVERVLEIIKQGVVALPKDR 618
Cdd:pfam09742 541 LQYQLDGNPNLVYALLRKREVFHQFANHPSFQDPLQNIDRVLQFFSPRVEKACADsglLSVSEILDIIQKGTLVGLLPK 619
 
Name Accession Description Interval E-value
Dymeclin pfam09742
Dyggve-Melchior-Clausen syndrome protein; Dymeclin (Dyggve-Melchior-Clausen syndrome protein) ...
1-618 0e+00

Dyggve-Melchior-Clausen syndrome protein; Dymeclin (Dyggve-Melchior-Clausen syndrome protein) contains a large number of leucine and isoleucine residues and a total of 17 repeated dileucine motifs. It is characteriztically about 700 residues long and present in plants and animals. Mutations in the gene coding for this protein in humans give rise to the disorder Dyggve-Melchior-Clausen syndrome (DMC, MIM 223800) which is an autosomal-recessive disorder characterized by the association of a spondylo-epi-metaphyseal dysplasia and mental retardation. DYM transcripts are widely expressed throughout human development and Dymeclin is not an integral membrane protein of the ER, but rather a peripheral membrane protein dynamically associated with the Golgi apparatus.


Pssm-ID: 462873  Cd Length: 645  Bit Score: 683.69  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624   1 MGSNSSRIGdlPKNEYLKKLSGTESISENDPFWNQLLSFSFPAPTSSSELKLLEEATISVCRSLVENNPRTGNLGALIKV 80
Cdd:pfam09742   1 MGASSSKLS--FRNAYLQLLSGTQPISADDPFWNQLLSFSLSIPLSSADVFLLEEALEPACEILALRNARTGNLATLLRK 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624  81 FLSRTKELK--LSAEC-QNHIFIWQTHNALFIICCLLKVFICQMSEEELQLHFTYEEKSPGNYSSDSEDLLEELLCCLM- 156
Cdd:pfam09742  79 FVERLVELKdsSRSASeQNDLFIWQALNALFLLRRILKYIIERASEEELLQHFEYENDDEGDEDEEGSNRDLPLAESLLl 158
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 157 ---QLITDIPLLDITYEISVEAISTMVVFLSCQLFHKEVLRQSISHKYLMRGPCL---PYTSKLVKTLLYNFIRQEKPPP 230
Cdd:pfam09742 159 alvDLLFTVPLTDSTYALHTELLNLLLVLLSEQLYSPPSPADTSIFNPFMDGKCSadsSIALPLVTSLLNNFIAYDPVPS 238
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 231 PGAHVFPQQSDGGGLLYGLASGVATGLWTVFTLGGvgSKAAASPELSSPLANQSLL-------LLLVLANLTDASDAPNP 303
Cdd:pfam09742 239 NSLDSDGGSGVPYNHLLGLVSDLASSLWLLPTLGG--SSESESEGTPEPLADQSLQlllvlldHGPTEDPVKSPSGGDNP 316
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 304 YRQAIMSFKNTQDsspfpssiphaFQINFNSLYTALCEQQTSDQA-TLLLYTLLHQNSNIRTYMLARTDMENLVLPILEI 382
Cdd:pfam09742 317 YRNALSRLHDVED-----------FQIVFSGLFRTLCNTVPSEQTlLLLLYKLLHSNSKFLNYVLSRSDVLDLLVPILEL 385
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 383 LYHVEERNSHHVYMALIILLILTEDDGFNRSIHEVILKNITWYSERVLTEISLGSLLILVVIRTIQYNMTRTRDKYLHTN 462
Cdd:pfam09742 386 LYNARADNSHHIYMALIILLILSEDRNFNKRLHKPILKNVTWYSERVPTEISLGSLLILVLIRTIQYNHTRLRDKYLHTN 465
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 463 CLAALANMSAQFRSLHQYAAQRIISLFSLLSKKHNKVLEQATQSLRGSLSSNdvplpDYAQDLNVIEEVIRMMLEIINSC 542
Cdd:pfam09742 466 CLAILANMSPYFKNLSPYASQRLVSLFELLSKKHFKLLSLANGKASNDLGSD-----DLAQDLSVNEEVLRLLLEILNSI 540
                         570       580       590       600       610       620       630
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 2462560624 543 LTNSLHHNPNLVYALLYKRDLFEQFRTHPSFQDIMQNIDLVISFFSSRLLQAGAE---LSVERVLEIIKQGVVALPKDR 618
Cdd:pfam09742 541 LQYQLDGNPNLVYALLRKREVFHQFANHPSFQDPLQNIDRVLQFFSPRVEKACADsglLSVSEILDIIQKGTLVGLLPK 619
Hid1 pfam12722
High-temperature-induced dauer-formation protein; Hid1 (high-temperature-induced ...
348-569 5.64e-07

High-temperature-induced dauer-formation protein; Hid1 (high-temperature-induced dauer-formation protein 1) represents proteins of approximately 800 residues long and is conserved from fungi to humans. Functionally it might be involved in vesicle secretion or be an inter-cellular signalling protein or be a novel insulin receptor. It was previously thought to contain up to seven potential transmembrane domains separated by regions of low complexity. However, biochemical membrane fraction analysis demonstrate that HID-1 is a peripheral membrane protein tightly associated with the Golgi apparatus but not a transmembrane protein predicted by the bioinformatic programs. Furthermore, it contains a conserved N-terminal myristoylation site was required for HID-1 binding to the Golgi apparatus.


Pssm-ID: 463680 [Multi-domain]  Cd Length: 804  Bit Score: 52.80  E-value: 5.64e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 348 ATLLLYTLLHQNSNIRTYMLARTDMENLVLPILeilYHV-EERN--SH--HVYMALIILLILTEDDGFNRSIHEVILKNi 422
Cdd:pfam12722 371 MLMLFWELLQCNKRFRSYVIDTSRALDLLVPIL---YYAfEYRSdpSKkgLVKICVFILLLLSGEKNFGVRLNKPFEAQ- 446
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2462560624 423 twysERVLTEI-------SLGSLLILVVIRTIQYNMTRTRDkyLHTNCLAALANMSAQFRSLHQYAAQRIISLFSLLSKk 495
Cdd:pfam12722 447 ----ETLPTSIripfftgTYADFLITVIHKLITTGKGRLSE--LVPCLLEILVNLSPYLKGLSMVACSKLLQLFESFSS- 519
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 2462560624 496 hnkvleqatqslRGSLSSNDVplpdyaqdlNviEEVIRMMLEIINSCLTNSLHHNPNLVYALLYKRDLFEQFRT 569
Cdd:pfam12722 520 ------------PSFLLANPS---------N--HKLLASLLEAFNNAIQYQFDGNPNLVYSILRNRKVFEALRN 570
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH